Clinical Trials Update: Dec. 7, 2006
Fungal Infections Dystonias Cold Sores (Herpes Labialis Infections)
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This research study will evaluate an already approved oral medication, in a new topical solution form, for toenail fungus. You may qualify if you are 12 to 75 years of age, have fungus on at least one of your big toes, and have not treated the fungus with oral medications in the past six months, prescription topical medications in the past three months, or over-the-counter topical medications in the past month.
The research site is in Chaska, Minn.
This clinical research study for people with dystonia will evaluate the safety and effectiveness of a refined form of botulinum A. Volunteers with a diagnosis of cervical dystonia or blepharospasm who have not had prior treatment using BOTOX for dystonia may be eligible.
The research site is in Bingham Farms, Mich.
Cold Sores (Herpes Labialis Infections)
This trial will investigate a topical cream and its effects on decreasing healing time and reducing the symptoms of cold sores and fever blisters. Candidates 18-65 who have a history of cold sores and fever blisters -- and are willing to come to the clinic within 24 hours of acquiring a new sore -- may be eligible. Additional criteria apply.
The research site is in New York, NY.
Copyright 2006 Thomson CenterWatch. All rights reserved.